XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Tesla allays investor fears with crucial EV growth forecast, shares jump



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Tesla allays investor fears with crucial EV growth forecast, shares jump</title></head><body>

By Abhirup Roy

SAN FRANCISCO, Oct 24 (Reuters) -Tesla TSLA.O stock shot up nearly 12% in pre-market trade on Thursday, a day after it forecast surging car sales growth, reassuring investors that CEO Elon Musk was still looking to expand the company's core business of selling electric vehicles.

The stock jump set the company up to add around $80 billion to its market capitalization, making up for a recent erosion in value caused by concerns that Musk was distracted by new projects like the recently unveiled robotaxi, which he has said will drive future growth.

Musk has been pivoting Tesla into an artificial intelligence and robotics company from an EV market leader, but has yet failed to lay out a detailed business plan for his new focus.

Last quarter, he made bold company announcements about everything but cars - from driverless taxis to humanoid robots - leaving investors worried about dwindling margins already squeezed by lowered prices.

On a post-earnings call on Wednesday, though, Musk forecast 20% to 30% sales growth next year, promising an affordable vehicle, and said efforts to slash production costs boosted margin.

"He definitely seemed more passionate and invested in it this time," said Jessica Caldwell, head of insights at car research and buying website Edmunds.

"I feel like so much of Tesla is tied up in the future but we need to figure out how you get there. That's what people needed to hear and they were a little bit better in providing those details than they have been in the past."

The results followed a flashy event this month to unveil a two-seater robotaxi dubbed Cybercab that will go into production in 2026 without a steering wheel or pedals and cost less than $30,000 to buy. The event also featured a 20-seater driverless van and humanoid robots that danced for attendees.

Disappointed by the lack of some key details on how quickly Tesla could ramp up robotaxi production and clear inevitable regulatory hurdles, investors punished the company's stock after that event.

Musk on Wednesday said Tesla aims to produce at least 2 million Cybercabs a year.

Not all investors are likely to be mollified by Tesla's reassurances on Wednesday.

Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management and a prominent Tesla investor, said robotaxis and AI were not the fundamental businesses he wanted Musk to focus on.

"The days were good when Elon slept at the factory. He was there every day, working. Not going on Trump rallies of all things he could be doing," Gerber said, referring to Musk's well-publicized support of the Republican presidential candidate. Gerber made a short-lived run for the Tesla board last year.

Musk on Thursday said he expects Tesla vehicles to offer paid, driverless, ride-hailing services next year, doubling down on his promise made at the robotaxi event. He said the company was already testing the operations with its employees in the San Francisco Bay Area.

But that plan is likely to face significant regulatory challenges.

Musk himself acknowledged on Wednesday the potential difficulties in getting approvals in California, saying "it's not something we totally control," but adding "I would be shocked if we don't get approval next year."

For now, encouraging fundamentals of the core EV business is likely to keep the heat off Musk. Until next quarter.

"Capturing sales in today's challenging market and streamlining operations aren't as sexy as self-driving cabs and dancing robots," Edmunds' Caldwell said. "But they're critical toward funding the company's long-term vision for the future."



Reporting by Abhirup Roy in San Francisco; Editing by Sayantani Ghosh, Sam Holmes and Rashmi Aich

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.